Inventor · disambiguated record
Kun Wen
Also filed as: WEN KUN
5 granted patents·2 pending applications·0 citations·filing 2018–2022
58Inventor score
Files withHINOVA PHARMACEUTICALS INC7
Top patents by PatentIndex Score
7 records- 0157US12194040B2FAK inhibitor and drug combination thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Jan 14, 2025·0 cites·5 claims
- 0256US11891379B2Deuterated Defactinib compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Feb 6, 2024·0 cites·12 claims
- 0352US2025051347A1Bifunctional chimeric heterocyclic compound and use thereof as androgen receptor degraderHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0444US11447477B2Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereofHINOVA PHARMACEUTICALS INC·Filed 2018·Granted Sep 20, 2022·0 cites·1 claims
- 0542US11591301B2Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Feb 28, 2023·0 cites·14 claims
- 0642US2023091225A1Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereofHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0741US11753392B2Method for synthesis of deuterated amide and deuterated sulfonamideHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Sep 12, 2023·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Kun Wen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →